ERBB4 and cancer: In addition to the receptors FGFR1, FGFR4 and ERBB4, the main effector AKT1 and its downstream effectors, MTOR, GSK3B, p21, WEE1, BAD and CREB5, which mediate cancer cell growth and progression, also exhibited marked changes in HPV-ind CCs.